Burning Rock Biotech (NASDAQ:
BNR) reported quarterly losses of $(0.11) per share. This is a 50 percent increase over losses of $(0.22) per share from the same period last year. The company reported $17.30 million in sales this quarter. This is a 1.44 percent increase over sales of $17.05 million the same period last year.